IDEXX Laboratories, Inc. (IDXX) Return on Equity (ROE): 70.38%
Is IDEXX Laboratories, Inc.’s return on equity (ROE) high or low?
IDEXX Laboratories, Inc.'s return on equity (ROE) of 70.38% is 14% below its 5-year average of 81.69%, near the low end of its 5-year range (55.65%–111.56%).
The return on equity (ROE) for IDEXX Laboratories, Inc. (IDXX) is 70.38% as of Wednesday, June 10, 2026. It is above its 12-month average by 15.72% (60.82%).
IDXX Return on Equity (ROE) Chart
IDXX Average Return on Equity (ROE) Chart
IDXX Current vs Average Return on Equity (ROE) Chart
IDXX Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
70.38%
RETURN ON EQUITY (ROE) AVG TTM
60.82%
RETURN ON EQUITY (ROE) AVG 3Y
72.53%
RETURN ON EQUITY (ROE) AVG 5Y
81.69%
RETURN ON EQUITY (ROE) AVG 10Y
-377.44%
RETURN ON EQUITY (ROE) AVG 15Y
-242.39%
RETURN ON EQUITY (ROE) AVG 20Y
-179.16%
CURRENT VS TTM AVG
+15.72%
CURRENT VS 3Y AVG
-2.96%
CURRENT VS 5Y AVG
-13.84%
CURRENT VS 10Y AVG
+118.65%
CURRENT VS 15Y AVG
+129.04%
CURRENT VS 20Y AVG
+139.28%
IDXX Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | — | 70.38% | 60.82% | 72.53% | 81.69% |
| Humana Inc. (HUM) | $43.78B | 6.08% | 7.05% | 11.93% | 15.09% |
| Agilent Technologies, Inc. (A) | $37.17B | 19.85% | 20.59% | 21.51% | 20.54% |
| Zoetis Inc. (ZTS) | $34.20B | 81.75% | 66.19% | 56.82% | 52.60% |
| Centene Corporation (CNC) | $31.94B | -30.07% | -10.46% | -1.37% | 1.10% |
| IQVIA Holdings Inc. (IQV) | $30.60B | 22.26% | 21.77% | 21.17% | 17.55% |
| DexCom, Inc. (DXCM) | $29.24B | 31.47% | 28.93% | 25.01% | 22.95% |
| Biogen Inc. (BIIB) | $29.00B | 7.36% | 8.42% | 11.86% | 16.52% |
| Veeva Systems Inc. (VEEV) | $26.73B | 12.89% | 12.42% | 12.32% | 13.45% |
| Regeneron Pharmaceuticals, Inc. (REGN) | $62.59B | 14.08% | 14.72% | 15.95% | 23.11% |
Return Analysis
ROE
70.4%
ROA
32.4%
IDEXX Laboratories, Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IDEXX Laboratories, Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for IDEXX Laboratories, Inc. (IDXX)?
- The return on equity (ROE) for IDXX stock is 70.38%.
- Is IDEXX Laboratories, Inc.'s return on equity (ROE) high or low?
- IDEXX Laboratories, Inc.'s return on equity (ROE) of 70.38% is 14% below its 5-year average of 81.69%, near the low end of its 5-year range (55.65%–111.56%).
- What is the TTM average return on equity (ROE) for IDEXX Laboratories, Inc. (IDXX)?
- The TTM average return on equity (ROE) for IDXX stock is 60.82%.
- What is the 3Y average return on equity (ROE) for IDEXX Laboratories, Inc. (IDXX)?
- The 3Y average return on equity (ROE) for IDXX stock is 72.53%.
- What is the 5Y average return on equity (ROE) for IDEXX Laboratories, Inc. (IDXX)?
- The 5Y average return on equity (ROE) for IDXX stock is 81.69%.
- What is the 10Y average return on equity (ROE) for IDEXX Laboratories, Inc. (IDXX)?
- The 10Y average return on equity (ROE) for IDXX stock is -377.44%.
- What is the 15Y average return on equity (ROE) for IDEXX Laboratories, Inc. (IDXX)?
- The 15Y average return on equity (ROE) for IDXX stock is -242.39%.
- What is the 20Y average return on equity (ROE) for IDEXX Laboratories, Inc. (IDXX)?
- The 20Y average return on equity (ROE) for IDXX stock is -179.16%.
IDEXX Laboratories, Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 65.99% |
| 2024-12-31 | 55.65% |
| 2023-12-31 | 56.92% |
| 2022-12-31 | 111.56% |
| 2021-12-31 | 107.95% |
| 2020-12-31 | 92.04% |
| 2019-12-31 | 241.01% |
| 2018-12-31 | -3963.32% |
| 2017-12-31 | -486.35% |
| 2016-12-31 | -204.93% |
| 2015-12-31 | -228.32% |
| 2014-12-31 | 154.79% |
| 2013-12-31 | 36.24% |
| 2012-12-31 | 28.02% |
| 2011-12-31 | 29.98% |
| 2010-12-31 | 24.60% |
| 2009-12-31 | 23.75% |
| 2008-12-31 | 26.51% |
| 2007-12-31 | 21.45% |
| 2006-12-31 | 22.86% |
| 2005-12-31 | 21.21% |
| 2004-12-31 | 19.70% |
| 2003-12-31 | 13.81% |
| 2002-12-31 | 13.31% |
| 2001-12-31 | 12.47% |
| 2000-12-31 | 14.00% |
| 1999-12-31 | 11.47% |
| 1998-12-31 | -4.94% |
| 1997-12-31 | -6.97% |
| 1996-12-31 | 10.10% |
Related Metrics
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jonathan J. Mazelsky